scispace - formally typeset
M

M. A. Cleary

Researcher at Boston Children's Hospital

Publications -  9
Citations -  376

M. A. Cleary is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Newborn screening & MCADD. The author has an hindex of 7, co-authored 9 publications receiving 354 citations.

Papers
More filters
Journal ArticleDOI

Magnetic resonance imaging of the brain in phenylketonuria

TL;DR: MRI changes, compatible with a disturbance in the water content of white matter, were present in all but 1 patient and the severity of abnormality was most strongly associated with the blood phenylalanine concentration at the time of imaging.
Journal ArticleDOI

Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change

TL;DR: The MRI changes in PKU are at least partially reversible by lowering the blood phenylalanine concentration, seen primarily in those in whom phenylAlanine levels were reduced to less than 900 mumol/L.
Journal ArticleDOI

Detection of inborn errors of metabolism in the newborn

TL;DR: It is important for paediatricians and neonatologists to keep in mind inborn errors of metabolism (IEMs) as a cause of illness in the neonatal period, as many disorders are treatable and, in most cases, successful outcome is dependent on a rapid diagnosis and early instigation of therapy.
Journal ArticleDOI

Trifunctional protein deficiency: Three families with significant maternal hepatic dysfunction in pregnancy not associated with E474Q mutation

TL;DR: Five families with trifunctional protein deficiency in which, during pregnancy, three mothers experienced significant hepatic disease when carrying an affected fetus are reported, suggesting that other defects in this enzyme complex might be responsible for maternal hepatic complications in pregnancy.
Journal ArticleDOI

Assessment of adult phenylketonuria.

TL;DR: The relevance of the findings of neurological deterioration, neuropsychological problems and brain imaging in adults with PKU are discussed, including neurological assessments, awareness of nutritional deficiencies, educational requirements and the risks of maternal PKU.